- Bortezomib-Containing Multimodality Treatment for Antibody-Mediated Rejection with Anti-HLA and Anti-AT1R Antibodies after Kidney Transplantation
-
Iesari S, Lai Q, Favi E, Pisani F
- KMID: 2419133
- Yonsei Med J.
- 2017 May;58(3):679-681.
- doi: 10.3349/ymj.2017.58.3.679
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
